MedTrace Logo

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

NCT06604039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2025-08-07

No results posted yet for this study

Summary

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

Conditions

  • Vascular Access Device

Interventions

DEVICE

Central venous catheter

Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis

Sponsors & Collaborators

  • Teleflex

    lead INDUSTRY

Principal Investigators

  • Amy Bardin · Teleflex Incorporated Clinical and Medical Affairs

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-08
Primary Completion
2034-12-07
Completion
2034-12-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06604039 on ClinicalTrials.gov